SAN DIEGO, Dec. 12, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT) focused on whether Ardent Health and certain of its top executives made false and/or misleading…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
